E-MAIL FOR SPONSORSHIP

Pharmaceutical Major Cipla Set to Acquire 26% Stake in AMP Solar’s SPV at ₹129 Million

AMP Solar Power Systems is a special purpose vehicle formed for the purpose of setting up a captive solar power project in Maharashtra

May 27, 2019

/ Soumik Dutta
/ Finance and M&A, Solar
thumbnail

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights


A filing made at the Bombay Stock Exchange (BSE) states that Mumbai-based global pharmaceutical major Cipla Limited has signed an agreement to acquire 26% stake on a fully diluted basis in AMP Solar Power Systems Private Limited.

ℹ️ This article is free for registered users. Sign in to continue reading.

Sign In to Continue Reading

Create a free account to access the full article and exclusive features from Mercom India's renewable energy coverage.

✓Access to free articles and news
✓Save articles for later reading
✓Personalized content recommendations
✓Newsletter subscriptions
Sign Up FreeLog In
thumbnail

Soumik Dutta

More articles from Soumik Dutta.
AcquisitionAMPSOLARBSECiplaEquitySolar
PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

RECENT POSTS